BTI-320

Boston Therapeutics Inc reports topline U.S.-based phase IIb study results of BTI-320 in patients with type 2 diabetes
Reuters
Thu, 10/9/14 - 10:54 am
Boston Therapeutics
type 2 diabetes
BTI-320
Boston Therapeutics to initiate Phase II clinical study of BTI-320 in U.S.
The Fly on the Wall
Tue, 03/4/14 - 09:18 am
Boston Therapeutics
BTI-320
diabetes